Developing a first in class regenerative therapy using exosomes derived from immortalized Neonatal Stem Cells to treat Cardiac Diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Baltimore
State: Maryland
Zip:
Country: United States
NeoProgen is a therapeutics company that focuses on advancing neonatal cardiac progenitor cells. The company specializes in the fields of biotechnology and cardiac therapy. NeoProgen was founded in 2018 and headquartered in Maryland, United States.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2019 | Seed Round | 3 | $1.5M |
(Momentum Fund) University System of Maryland TEDCO UM Ventures (Momentum Fund) University System of Maryland TEDCO UM Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|